Preclinical toxicology from a top pre-clinical Contract Research Organization in Kiev, Ukraine.
Our company is an independent Contract Research Organization based in the U.S. that provides preclinical drug trials in state-of-the art, GLP certified research facilities in Eastern Europe. Our testing facilities are overseen by the Ukrainian National Academy of Medical Sciences and Health Department and provide support for commercial development of new drug discoveries as part of their main purpose. The CRO was founded to offer the top-notch, low-cost services of these research sites to new bio-technology companies in the USA and EU, thereby offering an attractive option for promoting development programs rapidly and at much lower cost than other commercial CROs. We provide a broad range of preclinical trials including medicine safety, acute and chronic toxicity, pharma screening, bioavailability, bioequivalence, and extensive in vivo and in vitro screening for anticancer activity.
Our preclinical Contract Research Organization is able to price pre-clinical services far below other CROs since we have a very low overhead in the U.S. and perform all research in Ukraine where personnel and facility costs are much lower. Our staff in the USA is comprised of only of the company principals who work directly with clients; we have no marketing costs other than our web site, and no main offices, administrative staff or other overhead to inflate costs. We have much lower trials conduct costs in Kiev due to much lower labor rates and are happy to offer our best pricing for longer and more intricate preclinical tests where labor is the greatest part of the overall price. Because we utilize the same reliable international providers for lab animals, reagents and laboratory supplies as other Contract Research Organizations, we don’t have any cost savings on these items and so less overall cost savings for very short-term preclinical studies. But, regardless of your test protocol and length, our goal is to give our clients the greatest possible value for their money.